GVP Module XVI - Risk Minimisation Measures
OBJECTIVESThis course on Risk Minimisation Measures aims to give you a better understanding of the new obligations of MAH’s towards EU Risk Management System regulation described in the GVP Module XVI–Risk minimisation measures: selection of tools and effectiveness indicators (rev2).
LEARNING OUTCOMESBy the end of this course you will be able to
This course is built in relation to the GVP Module V - Risk Management Systems Rev2.
|
|
AUTHORS
![]() |
John Talbot AstraZeneca AB |
![]() |
Department Of Medical Pharmacology Université de Bordeaux |